Medications for Neoplasms

49 results

  • aminocaproic acid

    (AMINOCAPROIC ACID)
    Biocon Pharma Inc.
    Aminocaproic acid is indicated for enhancing hemostasis in scenarios where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, hepatic cirrhosis, and related neoplastic diseases. It is also used for excessive urinary tract bleeding following surgical or nonsurgical interventions.

  • axtle

    (pemetrexed)
    Avyxa Pharma, LLC
    AXTLE is indicated for the treatment of non-squamous non-small cell lung cancer (NSCLC) in combination with cisplatin, maintenance therapy after prior chemotherapy, and for recurrent NSCLC. It also treats unresectable malignant pleural mesothelioma in combination with cisplatin. Not for squamous NSCLC.

  • dactinomycin

    (DACTINOMYCIN)
    Eugia US LLC
    Dactinomycin for injection is indicated for treating Wilms tumor, rhabdomyosarcoma, Ewing sarcoma, metastatic nonseminomatous testicular cancer, and gestational trophoblastic neoplasia in adults and children. It is also used for regional perfusion in adults with locally recurrent or locoregional solid malignancies as part of palliative care.

  • dexamethasone

    (dexamethasone)
    Amneal Pharmaceuticals NY LLC
    This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.

  • e-z-hd

    (barium sulfate)
    E-Z-EM Canada Inc
    E-Z-HD is indicated for double-contrast radiographic examinations of the esophagus, stomach, and duodenum, aiding visualization of the gastrointestinal tract in patients aged 12 and older.

  • edecrin

    (ethacrynic acid)
    Bausch Health US, LLC
    EDECRIN is indicated for treating edema related to congestive heart failure, cirrhosis, renal disease, and nephrotic syndrome. It also manages ascites, idiopathic edema, and lymphedema, particularly in hospitalized pediatric patients. Intravenous use is designated for rapid diuresis in acute situations or when oral administration is not an option.

  • ethacrynic acid

    (Ethacrynic Acid)
    ScieGen Pharmaceuticals Inc
    Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed, including conditions like congestive heart failure, liver cirrhosis, renal disease, and short-term management of ascites, idiopathic edema, lymphedema, and in pediatric patients with congenital heart disease or nephrotic syndrome.

  • ethacrynic acid

    (Ethacrynic Acid)
    Amneal Pharmaceuticals NY LLC
    Ethacrynic acid tablets are indicated for edema treatment requiring stronger diuretics, including conditions like congestive heart failure, cirrhosis, renal disease, ascites, and more. Intravenous formulation is used for rapid diuresis or when oral administration is not feasible, such as in acute pulmonary edema.

  • fludeoxyglucose

    (Fludeoxyglucose F18)
    MIPS Cyclotron & Radiochemistry Facility
    Fludeoxyglucose F18 Injection is indicated for PET imaging in oncology to assess glucose metabolism in malignancies, in cardiology for evaluating left ventricular function in coronary artery disease, and in neurology to identify abnormal glucose metabolism related to epileptic seizures.

  • fludeoxyglucose f 18

    (Fludeoxyglucose F 18)
    The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute
    Fludeoxyglucose F-18 Injection, USP is indicated for positron emission tomography (PET) imaging in oncology for cancer evaluation, cardiology to assess myocardial function in coronary artery disease, and neurology to identify abnormal glucose metabolism related to epileptic seizures.